Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Medical Director of Amaris B. Clinic Shares Little-known Permanent Side Effects of Cryolipolysis (Fat Freezing Treatments) 2019-11-07 09:42
Johnson & Johnson and Lazada Group Enter Strategic Partnership 2019-11-07 09:00
First Asia-Pacific hospital treats patients with RayStation and Radixact 2019-11-07 09:00
AiCure Raises $24.5 Million Series C Round to Broaden Its Strategic Value for Life Sciences 2019-11-07 08:01
Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S. 2019-11-07 05:14
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364 2019-11-07 01:40
Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019 2019-11-07 01:00
EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports 2019-11-06 18:01
Nanoform Wins the CPhI Excellence in Pharma Award for Formulation 2019-11-06 17:21
ZEISS Again at CIIE, Leveraging Innovation with China Partners for Mutual Benefit and Win-Win Results 2019-11-06 16:34
Ping An Joins UNLEASH 2019 to Support Innovation for Sustainable Development Goals 2019-11-06 14:54
Olympus Unveils Corporate Strategy 2019-11-06 14:08
15 Years of P-MEC China Driving Global Pharma Technology Forward in China 2019-11-06 14:00
Wiley Partners With Editage to Enhance and Expand Services for Authors 2019-11-06 11:00
Xinhua Silk Road: E China's Hangzhou beefs up efforts to forge world-class biomedical innovation city 2019-11-06 09:27
MyDoc and Vietnam's largest listed insurance company to target soaring medical inflation in fastest growing segment of US$22 billion healthcare market 2019-11-06 08:15
Frost & Sullivan Distinguishes Inovalon as Company of the Year for Advancing the Healthcare Industry by Harnessing Massive-Scale Data and Advanced Analytics 2019-11-05 22:00
Boehringer Ingelheim Applauded by Frost & Sullivan for Continuing to Lead the Bio-CDMO Market with Its Cutting-edge Innovation 2019-11-05 21:00
Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab) 2019-11-05 21:00
Canadian Brand, PureForm Pet Health Supplements, First to Launch Earth-Friendly Packaging 2019-11-05 21:00
1 579 580 581 582 583 803